Company Profiles

driven by the PitchBook Platform

Recursion Pharmaceuticals

Recursion Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$60M LATEST DEAL AMOUNT
$79.2M TOTAL AMOUNT RAISED
Description

Provider of a drug discovery platform designed to interrogate complex biological interactions for drug re-purposing. The company's drug discovery platform uses biological tools to build cellular disease models, enabling biologists to query and understand the results of phenotypic screens, drug screens and target discovery screens with immediate access to raw images and underlying data.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
630 South Komas Drive
Suite 300
Salt Lake City, UT 84108
United States

+1 (385) 269-0203
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Recursion Pharmaceuticals’s full profile, request a free trial.

Recursion Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 03-Oct-2017 $60M $79.2M 00000 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 07-Feb-2017 0000 000.00 0000 Completed Startup
2. Grant 25-Feb-2015 $1.5M $170k Completed Startup
1. Seed Round 15-Aug-2014 $170k $170k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Recursion Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 20,052,268 $0.000010 $0.09 $1.07 $1.07 1x $1.07 28.53%
To view this company’s complete Cap Table request access »

Recursion Pharmaceuticals Investors (30)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AME Cloud Ventures Venture Capital Minority 000 0000 000000 0
Advantage Capital (St. Louis) Venture Capital Minority 000 0000 000000 0
Amplify Partners Venture Capital Minority 000 0000 000000 0
Amy Wages Angel (individual) Minority 000 0000 000000 0
Bart Robertson Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 30 investors. Get the full list »

Recursion Pharmaceuticals Executive Team (8)

Name Title Board
Seat
Contact
Info
Christopher Gibson Ph.D Co-Founder, Chief Executive Officer & Board Member
John Pereira Chief Operating Officer & Chief Marketing Officer
Blake Borgeson Ph.D Chief Technology Officer, Board Member and Co-Founder
Timothy Considine JD Senior Vice President of Strategic Development
Yolanda Chong Ph.D Vice President, Biology
You’re viewing 5 of 8 executives. Get the full list »

Recursion Pharmaceuticals Board Members (10)

Name Representing Role Since Contact
Info
Alaa Halawa Mubadala Investment Company Board Observer 000 0000
Blake Borgeson Ph.D Recursion Pharmaceuticals Chief Technology Officer, Board Member and Co-Founder 000 0000
Christopher Gibson Ph.D Recursion Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Dean Li Ph.D Recursion Pharmaceuticals Board Observer & Co-Founder 000 0000
James Hardiman Data Collective Board Observer 000 0000
You’re viewing 5 of 10 board members. Get the full list »